Article Information
History
- October 17, 2022.
Article Versions
- You are currently viewing Version 1 of this article (October 17, 2022 - 14:00).
- Version 2 (October 11, 2023 - 13:49).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Bonnie J. Lafleur1,2,
- Lisa White1,
- Michael D. Dake3,
- Janko Nikolich-Zugich1,4,5,
- Ryan Sprissler1,6 and
- Deepta Bhattacharya1,4,7,*
- 1BIO5 Institute, University of Arizona, Tucson, AZ, USA
- 2Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA
- 3Office of the Senior Vice-President for Health Sciences, University of Arizona, Tucson, AZ, USA
- 4Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
- 5University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ, USA
- 6University of Arizona Genomics Core and the Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ, USA
- 7Department of Surgery, University of Arizona College of Medicine, Tucson, AZ, USA
- ↵* Corresponding author; email: deeptab{at}arizona.edu
Posted October 17, 2022.
No evidence that analgesic use after COVID-19 vaccination negatively impacts antibody responses
